Related Experiment Video
Updated: May 27, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Surgical therapy for intermediate risk prostate cancer
George R Schade1, David P Wood
1Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.
Urologic Oncology
|November 15, 2011
Summary
Defining optimal surgical management for intermediate-risk prostate cancer is challenging due to disease heterogeneity. A balanced approach maximizing oncologic outcomes and quality of life is crucial, with multi-modality therapy available for patients with poor outcomes.
Area of Science:
- Urology
- Oncology
- Surgical Management
Background:
- Optimal surgical management for intermediate-risk prostate cancer remains undefined.
- Disease heterogeneity presents challenges in treatment selection.
- Balancing oncologic outcomes with quality of life is essential.
Purpose of the Study:
- To define optimal surgical management strategies for intermediate-risk prostate cancer.
- To address the heterogeneity of disease burden in this patient population.
- To guide urologists in maximizing oncologic outcomes while preserving quality of life.
Main Methods:
- Review of current surgical approaches for intermediate-risk prostate cancer.
- Analysis of factors influencing oncologic outcomes and quality of life.
- Consideration of multi-modality therapy options.
Main Results:
- Surgical management must account for individual patient disease burden.
- A personalized approach is necessary to balance cancer control and quality of life.
- Multi-modality therapy is indicated for patients with poor pathologic outcomes post-surgery.
Conclusions:
- Optimal surgical management for intermediate-risk prostate cancer requires a tailored approach.
- Urologists must weigh oncologic control against quality of life.
- Adjuvant or salvage multi-modality therapy is vital for select patients post-surgery.
